SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-003314
Filing Date
2021-03-19
Accepted
2021-03-19 09:30:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27745
2 filename2.txt TEXT-EXTRACT 1722
  Complete submission text file 0000000000-21-003314.txt   40576
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filed for) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)